You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 267 No. 4, January 22, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Iron Supplementation After Femoral Head Replacement for Patients With Normal Iron Stores

N. Peter Zauber, MD; Ann Graham Zauber, PhD; Frederick J. Gordon, MD; Alan C. Tillis, MD; Harold C. Leeds, MD; Errol Berman, MD; Alexander B. Kudryk, MD

JAMA. 1992;267(4):525-527.


Abstract

Objective.
—To assess the efficacy of oral iron therapy in the recovery of patients' hemoglobin levels after major surgery.

Design.
—Randomized controlled trial.

Setting.
—Private orthopedic practice confined to one large community hospital.

Patients.
—One hundred seventy consecutive elderly patients undergoing hip surgery; 75 failed to meet entry hematologic or medical criteria; 95 were randomized, with 16 withdrawn because of complications.

Intervention.
—Thirty-seven patients received ferrous sulfate orally four times a day for the duration of their hospitalization. Forty-two patients who received no iron supplement served as the control group.

Main Outcome Measures.
—Changes in hemoglobin levels and reticulocyte counts over the 2- to 3-week follow-up period.

Results.
—There was no significant difference in mean hemoglobin levels between the treatment and control groups (95% confidence interval [Cl] for difference of —6.6 to 5.4 g/L). Corrected reticulocyte fractions increased equally in both groups (95% Cl for difference of —9 x 103 to 2 x 10-3. The study was designed to detect a difference in mean hemoglobin levels of 8.5 g/L or greater or a difference in mean reticulocyte fraction of 10 x 10-3 between the two groups with a power of 0.80 at the .05 (two-sided) level of significance.

Conclusion.
—The administration of oral iron supplements to elderly, healthy orthopedic patients postoperatively did not hasten the recovery of hemoglobin levels, provided adequate tissue iron stores were present.

(JAMA. 1992;267:525-527)



Author Affiliations

From the Departments of Medicine (Drs N. P. Zauber and Kudryk), Orthopedic Surgery (Drs Gordon, Tillis, and Leeds), and Pathology (Dr Berman), St Barnabas Medical Center, Livingston, NJ, and the Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY (Dr A. G. Zauber).


Footnotes

Reprint requests to 22 Old Short Hills Rd, Livingston, NJ 07039 (Dr N. P. Zauber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perioperative anaemia management: consensus statement on the role of intravenous iron
Beris et al.
Br J Anaesth 2008;100:599-604.
ABSTRACT | FULL TEXT  

The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty
Mundy et al.
J Bone Joint Surg Br 2005;87-B:213-217.
ABSTRACT | FULL TEXT  

IS IRON SUPPLEMENTATION NEEDED AFTER SURGICAL BLOOD LOSS
JWatch General 1992;1992:5-5.
FULL TEXT  

A Tradition of Testing Ironclad Practices
Swerdlow
JAMA 1992;267:560-561.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.